Grand Rounds Presentation on Advances in Gastric Cancer
Gastric surgeon Vivian Strong talks about improved staging, progress in surgical technologies, and other advances in gastric cancer treatment in this Grand Rounds presentation.
Runtime: 26:00 minutes Published: 11/12/2012 - 10:44 AM
Phase III Trial for Patients with Myelodysplastic Syndromes and Symptomatic Anemia
Medical oncologist Virginia Klimek discusses a randomized clinical trial for patients with myelodysplastic syndromes (MDS) and symptomatic anemia. The standard treatments for MDS include red blood cell transfusions and erythropoietin injections, but many patients do not respond well to these therapies. Memorial Sloan-Kettering Cancer Center is participating in a multicenter Eastern Cooperative Oncology Group study that is assessing the effectiveness of combining lenalidomide with erythropoietin injections.
Runtime: 04:00 minutes Published: 11/01/2012 - 10:07 AM
Vascular Targeted Photodynamic Therapy for Prostate Tumors
Urologic surgeon Jonathan Coleman discusses vascular targeted photodynamic (VTP) therapy for delivering intravenous TOOKAD® to destroy prostate tumors and the blood vessels that support them.
Runtime: 01:53 minutes Published: 08/15/2012 - 1:18 PM
Prostate Cancer Treatment via Focal Therapies
Urologic surgeon Jonathan Coleman discusses novel forms of focal therapy that may benefit select patients with localized prostate cancer.
Runtime: 03:49 minutes Published: 08/15/2012 - 1:07 PM
Grand Rounds Presentation on Curing Rectal Cancer
Gastrointestinal Oncology Service Chief Leonard Saltz talks about advances in the personalized treatment and cure of rectal cancer in this Grand Rounds presentation.
Runtime: 54:00 minutes Published: 01/24/2012 - 7:30 AM
Developing New Treatments for T Cell Lymphoma
Medical oncologist Steven M. Horwitz discusses the development and impact of three new, widely used therapies for T cell lymphoma: pralatrexate, romidepsin, and brentuximab vedotin.
Runtime: 05:00 minutes Published: 12/27/2011 - 10:48 AM
Romiplostim in Chemotherapy-Induced Thrombocytopenia (2011 ASH Conference)
Thrombocytopenia is a common effect of cytotoxic chemotherapy regimens in cancer patients, often necessitating reduction or delay in subsequent cycles. While the thrombocytopenia typically resolves with time, a subset of patients with chemotherapy-induced thrombocytopenia (CIT) have prolonged thrombocytopenia, of idiopathic etiology, that interferes with subsequent treatment.
Runtime: 02:00 minutes Published: 12/10/2011 - 10:35 AM
Leading-Edge Image-Guided Techniques
Stephen Solomon, an interventional radiologist at Memorial Sloan-Kettering, discusses the variety of image-guided therapies we offer patients.
Runtime: 6:00 minutes Published: 09/14/2011 - 12:00 AM
Immune-based Gene Therapy for Cancer
MSKCC scientists are engineering immune-system cells called T cells so that they can identify and destroy leukemia and prostate cancer cells.
Runtime: 6:00 minutes Published: 05/01/2011 - 12:00 AM
Development of Next Generation Anti-Androgens
Medical oncologist Howard Scher describes new anti-androgen therapies for prostate cancer that returns after hormone therapy.
Runtime: 4:00 minutes Published: 03/01/2011 - 12:00 AM